Hyemin Jang, Daeun Shin, Yeshin Kim, Ko Woon Kim, Juyoun Lee, Jun Pyo Kim, Hee Jin Kim, Soo Hyun Cho, Si Eun Kim, Duk L Na, Sang Won Seo
{"title":"韩国-克服痴呆症和加速痴呆症研究(K-ROAD):痴呆症研究和特定种族洞察的队列。","authors":"Hyemin Jang, Daeun Shin, Yeshin Kim, Ko Woon Kim, Juyoun Lee, Jun Pyo Kim, Hee Jin Kim, Soo Hyun Cho, Si Eun Kim, Duk L Na, Sang Won Seo","doi":"10.12779/dnd.2024.23.4.212","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and purpose: </strong>Dementia, particularly Alzheimer's disease, is a significant global health concern, with early diagnosis and treatment development being critical goals. While numerous cohorts have advanced dementia research, there is a lack of comprehensive data on ethnic differences, particularly for the Korean population. The Korea-Registries to Overcome Dementia and Accelerate Dementia Research (K-ROAD) aims to establish a large-scale, hospital-based dementia cohort to address this gap, with a focus on understanding disease progression, developing early diagnostics, and supporting treatment advancements specific to the Korean population.</p><p><strong>Methods: </strong>K-ROAD comprises multiple prospective cohorts. Participants underwent clinical evaluations, neuroimaging, and biomarker analysis, with data collected on a range of clinical and genomic markers.</p><p><strong>Results: </strong>As of December 2023, K-ROAD has recruited over 5,800 participants, including individuals across the Alzheimer's clinical syndrome, subcortical vascular cognitive impairment, and frontotemporal dementia spectra. Preliminary findings highlight significant ethnic differences in amyloid positivity, cognitive decline, and biomarker profiles, compared to Western cohorts.</p><p><strong>Conclusions: </strong>The K-ROAD cohort offers a unique and critical resource for dementia research, providing insights into ethnic-specific disease characteristics and biomarker profiles. These findings will contribute to the development of personalized diagnostic and therapeutic approaches to dementia, enhancing global understanding of the disease.</p>","PeriodicalId":72779,"journal":{"name":"Dementia and neurocognitive disorders","volume":"23 4","pages":"212-223"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11538854/pdf/","citationCount":"0","resultStr":"{\"title\":\"Korea-Registries to Overcome Dementia and Accelerate Dementia Research (K-ROAD): A Cohort for Dementia Research and Ethnic-Specific Insights.\",\"authors\":\"Hyemin Jang, Daeun Shin, Yeshin Kim, Ko Woon Kim, Juyoun Lee, Jun Pyo Kim, Hee Jin Kim, Soo Hyun Cho, Si Eun Kim, Duk L Na, Sang Won Seo\",\"doi\":\"10.12779/dnd.2024.23.4.212\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and purpose: </strong>Dementia, particularly Alzheimer's disease, is a significant global health concern, with early diagnosis and treatment development being critical goals. While numerous cohorts have advanced dementia research, there is a lack of comprehensive data on ethnic differences, particularly for the Korean population. The Korea-Registries to Overcome Dementia and Accelerate Dementia Research (K-ROAD) aims to establish a large-scale, hospital-based dementia cohort to address this gap, with a focus on understanding disease progression, developing early diagnostics, and supporting treatment advancements specific to the Korean population.</p><p><strong>Methods: </strong>K-ROAD comprises multiple prospective cohorts. Participants underwent clinical evaluations, neuroimaging, and biomarker analysis, with data collected on a range of clinical and genomic markers.</p><p><strong>Results: </strong>As of December 2023, K-ROAD has recruited over 5,800 participants, including individuals across the Alzheimer's clinical syndrome, subcortical vascular cognitive impairment, and frontotemporal dementia spectra. Preliminary findings highlight significant ethnic differences in amyloid positivity, cognitive decline, and biomarker profiles, compared to Western cohorts.</p><p><strong>Conclusions: </strong>The K-ROAD cohort offers a unique and critical resource for dementia research, providing insights into ethnic-specific disease characteristics and biomarker profiles. These findings will contribute to the development of personalized diagnostic and therapeutic approaches to dementia, enhancing global understanding of the disease.</p>\",\"PeriodicalId\":72779,\"journal\":{\"name\":\"Dementia and neurocognitive disorders\",\"volume\":\"23 4\",\"pages\":\"212-223\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11538854/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Dementia and neurocognitive disorders\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12779/dnd.2024.23.4.212\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/10/22 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dementia and neurocognitive disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12779/dnd.2024.23.4.212","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/22 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景和目的:痴呆症,尤其是阿尔茨海默病,是全球关注的重大健康问题,早期诊断和治疗发展是关键目标。虽然许多队列研究推动了痴呆症的研究,但缺乏有关种族差异的全面数据,尤其是韩国人口的数据。韩国-克服痴呆症和加速痴呆症研究(Korea-Registries to Overcome Dementia and Accelerated Dementia Research,K-ROAD)旨在建立一个大规模的、以医院为基础的痴呆症队列,以弥补这一不足,重点是了解疾病进展、开发早期诊断方法以及支持韩国人群的治疗进展:K-ROAD由多个前瞻性队列组成。方法:K-ROAD由多个前瞻性队列组成,参与者接受了临床评估、神经影像学检查和生物标志物分析,并收集了一系列临床和基因组标志物数据:截至 2023 年 12 月,K-ROAD 共招募了 5800 多名参与者,其中包括阿尔茨海默氏症临床综合征、皮层下血管性认知障碍和额颞叶痴呆谱系的患者。初步研究结果表明,与西方队列相比,在淀粉样蛋白阳性率、认知能力下降和生物标志物特征方面存在明显的种族差异:K-ROAD队列为痴呆症研究提供了独特而重要的资源,使人们能够深入了解特定种族的疾病特征和生物标志物特征。这些发现将有助于开发痴呆症的个性化诊断和治疗方法,增进全球对该疾病的了解。
Korea-Registries to Overcome Dementia and Accelerate Dementia Research (K-ROAD): A Cohort for Dementia Research and Ethnic-Specific Insights.
Background and purpose: Dementia, particularly Alzheimer's disease, is a significant global health concern, with early diagnosis and treatment development being critical goals. While numerous cohorts have advanced dementia research, there is a lack of comprehensive data on ethnic differences, particularly for the Korean population. The Korea-Registries to Overcome Dementia and Accelerate Dementia Research (K-ROAD) aims to establish a large-scale, hospital-based dementia cohort to address this gap, with a focus on understanding disease progression, developing early diagnostics, and supporting treatment advancements specific to the Korean population.
Methods: K-ROAD comprises multiple prospective cohorts. Participants underwent clinical evaluations, neuroimaging, and biomarker analysis, with data collected on a range of clinical and genomic markers.
Results: As of December 2023, K-ROAD has recruited over 5,800 participants, including individuals across the Alzheimer's clinical syndrome, subcortical vascular cognitive impairment, and frontotemporal dementia spectra. Preliminary findings highlight significant ethnic differences in amyloid positivity, cognitive decline, and biomarker profiles, compared to Western cohorts.
Conclusions: The K-ROAD cohort offers a unique and critical resource for dementia research, providing insights into ethnic-specific disease characteristics and biomarker profiles. These findings will contribute to the development of personalized diagnostic and therapeutic approaches to dementia, enhancing global understanding of the disease.